| 产品详情 |
| Edit |   |
|---|
| Product Name | Adenosine A1 Receptor Agonist II, CCPA |
|---|
| Description | Purity ~99% (HPLC). An adenosine analog that acts as a selective, high affinity agonist for Adenosine A1 receptor (A1R) (Ki = 800 pM; 2.3uM, 18.8uM, and 42nM for human A1, A2A, A2B, A3 respectively). Shown to be centrally active following systemic administration and exhibits anti-convulsive effects. Also reported to inhibit adenylate cyclase activity in rat fat cell membrane (IC50 = 33nM). Diminishes respiratory rhythm, reduces heart rate, and enhances the activity of KATP channels. Reduces norepinephrine release by about 50% in untreated and pertussis toxin treated hearts. Solubility: DMSO or H2O Primary Target: A1 Primary Target Ki: 2.3nM Molar Mass: 369.8 |
|---|
| Size | 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Adenosine A1 Receptor Agonist II, CCPA ((2R,3R,4S,5R)-2-(2-chloro-6-(cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 2-Chloro-N6-cyclopentyladenosine) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 217149 |
|---|
| Price | |
|---|
| Order / More Info | Adenosine A1 Receptor Agonist II, CCPA from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|